Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Healon D
- Development stage
- Unknown
- Lead developer
- AMO Japan
- Administration
- Ophthalmic
01
Overview
Healon D is a dispersive ophthalmic viscosurgical device (OVD) composed of a low molecular weight formulation of sodium hyaluronate. Developed by Advanced Medical Optics (now Johnson & Johnson Vision), it is specifically designed to coat and protect the corneal endothelium and other intraocular tissues during complex ophthalmic procedures. Its dispersive nature allows it to remain in the eye during irrigation and aspiration, providing a protective barrier throughout surgery. It is indicated for use as a surgical aid in cataract extraction, intraocular lens (IOL) implantation, corneal transplant, and glaucoma filtration surgery, where it helps maintain the anterior chamber and facilitates tissue manipulation.
- Brand names
- Healon D
- Other names
- sodium hyaluronate
Beyond the preview
Go deeper on Healon D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Healon D.